Amyloid · 2005 · 23 citations · 42 references
Life SciencesNeurosciencePharmacologyDrug DiscoveryMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationCombinatorial Peptide SynthesisNeurodegenerative Disease PharmacologyPeptide ChemistryPeptide Drug DiscoveryAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid InhibitionAmyloid PlaquesInhibition Of Amyloid FormationPeptide Library DesignPeptide Library ScreeningTherapeutic Targeting Of Amyloid
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular amyloid plaques, cerebrovascular amyloid deposits, intracellular neurofibrillary tangles, and neuronal loss. Amyloid deposits are composed of insoluble fibers of a 39-43 amino acid peptide named the amyloid beta-protein (A beta). Neuropathological and genetic studies provide strong evidence of a key role for A beta amyloidosis in the pathogenesis of AD. Therefore, an obvious pharmacological target for treatment of AD is the inhibition of amyloid growth and/or inhibition of amyloid function. We took an unbiased approach to generate new inhibitors of amyloid formation by screening a FliTrx combinatorial peptide library for A beta binding peptides and identified four groups of peptides with different A beta binding motifs. In addition, we designed and examined peptides mimicking the A beta binding domain of transthyretin (TTR). Our results showed that A beta binding peptides selected from FliTrx peptide library and from TTR-peptide analogs are capable of inhibiting A beta aggregation and A beta deposition in vitro. These properties demonstrate that binding of selected peptides to the amyloid beta-protein may provide potent therapeutic compounds for the treatment AD.
42
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Dale Schenk, Robin Barbour, Whitney Dunn et al. · Nature · 1999 · 3.2K citations
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Dora Games, David S. Adams, Ree Alessandrini et al. · Nature · 1995 · 2.5K citations
Amyloid β-peptide is produced by cultured cells during normal metabolism
Christian Haass, Michael G. Schlossmacher, Albert Y. Hung et al. · Nature · 1992 · 1.9K citations
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Peter Seubert, Carmen Vigo‐Pelfrey, Fred Esch et al. · Nature · 1992 · 1.7K citations